These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3886210)

  • 21. Insulin resistance and insulin secretion in non-diabetic acromegalic patients.
    Coculescu M; Niculescu D; Lichiardopol R; Purice M
    Exp Clin Endocrinol Diabetes; 2007 May; 115(5):308-16. PubMed ID: 17516294
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of CB-154 therapy on the glucose tolerance, IRI and GH response to glucose administration in acromegaly.
    Demura R; Yamaguchi H; Demura H; Shizume K
    Endocrinol Jpn; 1978 Aug; 25(4):355-9. PubMed ID: 710371
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Postoperative plasma GH levels and restoration of GH dynamics in acromegalic patients surgically treated by the transsphenoidal approach.
    Karashima T; Kato K; Nawata H; Ikuyama S; Ibayashi H; Nakagaki H; Kitamura K
    Clin Endocrinol (Oxf); 1986 Aug; 25(2):157-63. PubMed ID: 3791660
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Homocysteine levels in acromegaly patients.
    Hekimsoy Z; Ozmen B; Ulusoy S
    Neuro Endocrinol Lett; 2005 Dec; 26(6):811-4. PubMed ID: 16380700
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factors determining the long-term outcome of surgery for acromegaly.
    Osman IA; James RA; Chatterjee S; Mathias D; Kendall-Taylor P
    QJM; 1994 Oct; 87(10):617-23. PubMed ID: 7987657
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term treatment of acromegaly with Sandostatin (SMS 201-995). Normalization of most anomalous growth hormone responses.
    Pieters GF; van Liessum PA; Smals AG; van Gennep JA; Benraad TJ; Kloppenborg PW
    Acta Endocrinol Suppl (Copenh); 1987; 286():9-18. PubMed ID: 2892339
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum lipoproteins in acromegaly before and 6-15 months after transsphenoidal adenomectomy.
    Oscarsson J; Wiklund O; Jakobsson KE; Petruson B; Bengtsson BA
    Clin Endocrinol (Oxf); 1994 Nov; 41(5):603-8. PubMed ID: 7828349
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Growth hormone responses to oral glucose and intravenous thyrotropin-releasing hormone in acromegalic patients treated by slow-release lanreotide.
    Díez JJ; Iglesias P; Gómez-Pan A
    J Endocrinol Invest; 2001 May; 24(5):303-9. PubMed ID: 11407648
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term results of transsphenoidal pituitary microsurgery in 60 acromegalic patients.
    Roelfsema F; van Dulken H; Frölich M
    Clin Endocrinol (Oxf); 1985 Nov; 23(5):555-65. PubMed ID: 4085133
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical indicators of biochemical remission in acromegaly: does incomplete disease control always mean therapeutic failure?
    Damjanovic SS; Neskovic AN; Petakov MS; Popovic V; Macut D; Vukojevic P; Joksimovic MM
    Clin Endocrinol (Oxf); 2005 Apr; 62(4):410-7. PubMed ID: 15807870
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endogenous hyperinsulinemia and release of growth hormone following a glucose load as well as in response to thyrotropin releasing hormone in acromegaly.
    Saad MJ; Moreira AC; Foss MC
    Braz J Med Biol Res; 1990; 23(10):953-7. PubMed ID: 2129261
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Somatomedin-C levels in treated and untreated patients with acromegaly.
    Roelfsema F; Frölich M; Van Dulken H
    Clin Endocrinol (Oxf); 1987 Feb; 26(2):137-44. PubMed ID: 3665113
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of bromocriptine on insulin secretion and glucose tolerance in patients with acromegaly.
    Feek CM; Bevan JS; Taylor S; Brown NS; Baird JD
    Clin Endocrinol (Oxf); 1981 Nov; 15(5):473-8. PubMed ID: 7035013
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Age changes the diagnostic accuracy of mean profile and nadir growth hormone levels after oral glucose in postoperative patients with acromegaly.
    Colao A; Pivonello R; Cavallo LM; Gaccione M; Auriemma RS; Esposito F; Cappabianca P; Lombardi G
    Clin Endocrinol (Oxf); 2006 Aug; 65(2):250-6. PubMed ID: 16886969
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chronic bromocriptine treatment and glucose intolerance in acromegaly.
    Popović V; Micić D; Nesović M; Djordjević P; Mićić J; Djurić DS
    Exp Clin Endocrinol; 1985 Jun; 85(3):351-7. PubMed ID: 3899685
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Do "so-called" normal growth hormone concentrations (2-5 micrograms/l) indicate cure in acromegaly?
    Levitt NS; Ratanjee BD; Abrahamson MJ
    Horm Metab Res; 1995 Apr; 27(4):185-8. PubMed ID: 7750902
    [TBL] [Abstract][Full Text] [Related]  

  • 37. No differences in metabolic outcomes between nadir GH 0.4 and 1.0 ng/mL during OGTT in surgically cured acromegalic patients (observational study).
    Ku CR; Choe EY; Hong JW; Kim EH; Park SH; Kim SH; Lee EJ
    Medicine (Baltimore); 2016 Jun; 95(24):e3808. PubMed ID: 27310957
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of the paradoxical growth hormone inhibitory effect of galanin in acromegaly.
    Giustina A; Bresciani E; Bussi AR; Bollati A; Bonfanti C; Bugari G; Chiesa L; Giustina G
    J Clin Endocrinol Metab; 1995 Apr; 80(4):1333-40. PubMed ID: 7536207
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The impact of transsphenoidal surgery on glucose homeostasis and insulin resistance in acromegaly.
    Stelmachowska-Banaś M; Zieliński G; Zdunowski P; Podgórski J; Zgliczyński W
    Neurol Neurochir Pol; 2011; 45(4):328-34. PubMed ID: 22101993
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Insulin resistance in acromegaly: evaluation by studies of insulin binding to erythrocytes.
    Lerario AC; el-Andere W; Wajchenberg BL; Ohnuma LY; Rocha MH; Andriolo A
    J Endocrinol Invest; 1989 Mar; 12(3):155-61. PubMed ID: 2656831
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.